Platelet function during cardiopulmonary bypass not changed by two different doses of aprotinin.
暂无分享,去创建一个
J. Fontcuberta | J. Souto | J. Mateo | A. Santamaría | E. Muñiz‐Díaz | H. Litvan | A. Oliver | J. Murillo | E. Muñiz-Díaz
[1] L. Shore-lesserson,et al. Platelet Function and Cardiopulmonary Bypass , 2001 .
[2] P. Gazzaniga,et al. Is Soluble P-selectin Determination a More Reliable Marker of In Vivo Platelet Activation than CD62P Flow Cytometric Analysis? , 1999, Thrombosis and Haemostasis.
[3] S. Noble,et al. Aprotinin , 2012, Drugs.
[4] A. Schmaier,et al. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. , 1997, Blood.
[5] H. Kojima,et al. Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary bypass. , 1997, Circulation.
[6] M. Ray,et al. Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass. , 1997, The Annals of thoracic surgery.
[7] G. Schmitz,et al. Aprotinin Has no Effect on Platelet Activation and Adhesion during Cardiopulmonary Bypass , 1996, Thrombosis and Haemostasis.
[8] T. Shankey,et al. Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operations. , 1996, The Annals of thoracic surgery.
[9] P. Noris,et al. Platelet composition and function in patients undergoing cardiopulmonary bypass for heart surgery. , 1996, Haematologica.
[10] J. Fontcuberta,et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study. , 1995, The Journal of thoracic and cardiovascular surgery.
[11] W. van Oeveren,et al. Aprotinin effect on platelet function and clotting during cardiopulmonary bypass. , 1994, European Journal of Cardio-Thoracic Surgery.
[12] A. Michelson,et al. Aprotinin reduces cardiopulmonary bypass‐induced blood loss and inhibits fibrinolysis without influencing platelets , 1993, British journal of haematology.
[13] D. Green,et al. Effect of recombinant aprotinin on platelet activation in patients undergoing open heart surgery. , 1993, Haemostasis.
[14] R. Colman,et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. , 1993, The Journal of thoracic and cardiovascular surgery.
[15] B. Pasche,et al. The platelet function defect of cardiopulmonary bypass. , 1993, Blood.
[16] G. Hempelmann,et al. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss. , 1993, The Journal of thoracic and cardiovascular surgery.
[17] Z. Su,et al. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. , 1993, The Journal of thoracic and cardiovascular surgery.
[18] R. Mohr,et al. Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study. , 1993, The Annals of thoracic surgery.
[19] A. Lusky,et al. Aprotinin Prevents Cardiopulmonary Bypass‐Induced Platelet Dysfunction: A Scanning Electron Microscope Study , 1992, Circulation.
[20] P. Noris,et al. Platelet function after in vivo and in vitro treatment with thrombolytic agents. , 1992, The American journal of cardiology.
[21] R. Mohr,et al. Platelet protection by aprotinin in cardiopulmonary bypass: electron microscopic study. , 1992, The Annals of thoracic surgery.
[22] J. Soria,et al. Hemostasis in Patients Undergoing Extracorporeal Circulation: The Effect of Aprotinin (Trasylol) , 1991, Thrombosis and Haemostasis.
[23] J. Mathew,et al. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. , 1991, Anesthesiology.
[24] M. Turina,et al. Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass , 1991, The Lancet.
[25] J. E. Doran,et al. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.
[26] H. Teufelsbauer,et al. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation. , 1991, The Journal of thoracic and cardiovascular surgery.
[27] W. van Oeveren,et al. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.
[28] L. Eijsman,et al. PLATELET PRESERVATION BY APROTININ DURING CARDIOPULMONARY BYPASS , 1988, The Lancet.
[29] W. van Oeveren,et al. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. , 1987, The Annals of thoracic surgery.